Featured Research

from universities, journals, and other organizations

Metabolic Syndrome Associated With Cognitive Decline In Elderly Persons

Date:
November 16, 2004
Source:
Journal Of The American Medical Association
Summary:
Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.

Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA. The researchers also found a link with high measurements of certain proteins in the blood and the metabolic syndrome and impairment.

According to background information in the article, several studies have reported an association between the metabolic syndrome and cardiovascular disease. Despite an increasing awareness that cardiovascular risk factors increase risk of cognitive decline and dementia, there is little data on any link between the metabolic syndrome and cognition.

Kristine Yaffe, M.D., from the University of California, San Francisco, and colleagues investigated the association between the metabolic syndrome and high inflammation with change in cognition. Inflammation was defined as elevated levels of the proteins interleukin 6 and C-reactive protein in the blood. Participants, aged 70 to 79 years, were part of the Health, Aging and Body Composition (ABC) study, conducted from 1997 to 2002. Average age of the 2,632 participants at the study's onset was 74 years; 52 percent were women; 40 percent were black. Participants were reevaluated at three and five years.

The researchers found that compared with those without the metabolic syndrome (n = 1,616), persons with the metabolic syndrome (n = 1016) were 20 percent more likely to develop cognitive impairment (defined as at least a 5 point decline on the Modified Mini-Mental State Examination [3MS], a standard cognitive test). Those with both metabolic syndrome and high inflammation (n = 348) were 66 percent more likely to have cognitive impairment than those without the metabolic syndrome. The 668 participants who had the metabolic syndrome and low inflammation did not show an increased likelihood of impairment. Also, those with the metabolic syndrome and high inflammation had greater four-year decline in cognitive testing scores than those without the metabolic syndrome, while those with the metabolic syndrome and low inflammation did not.

"To our knowledge, this is the first study to document that the metabolic syndrome is associated with poor cognitive outcomes," the researchers write. "Future studies will need to address whether preventing the metabolic syndrome or lowering inflammation prevents cognitive impairment in elderly individuals."

###

(JAMA. 2004; 292:2237-2242. Available post-embargo at JAMA.com)

Editor's Note: This work was supported by grants from the National Institutes of Health. Dr. Yaffe is supported by the Paul Beeson Faculty Scholars Program, The Mt. Zion/UCSF Women's Health Grant, and a grant from the National Institutes of Health.


Story Source:

The above story is based on materials provided by Journal Of The American Medical Association. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The American Medical Association. "Metabolic Syndrome Associated With Cognitive Decline In Elderly Persons." ScienceDaily. ScienceDaily, 16 November 2004. <www.sciencedaily.com/releases/2004/11/041116220336.htm>.
Journal Of The American Medical Association. (2004, November 16). Metabolic Syndrome Associated With Cognitive Decline In Elderly Persons. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/11/041116220336.htm
Journal Of The American Medical Association. "Metabolic Syndrome Associated With Cognitive Decline In Elderly Persons." ScienceDaily. www.sciencedaily.com/releases/2004/11/041116220336.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins